A method for gene editing in fish and its application

By using the Cas-SF01 protein and optimized gRNA design and temperature treatment, the problems of inflexible target selection and low editing efficiency in fish gene editing were solved, realizing a highly efficient fish gene editing method. This method expands the range of target selection and improves editing efficiency, making it suitable for various application scenarios.

CN122484209BActive Publication Date: 2026-11-10INST OF AQUATIC LIFE ACAD SINICA +2
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202610978767.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2026-07-02
Publication Date
2026-11-10
Estimated Expiration
2046-07-02

AI Technical Summary

Technical Problem

Existing CRISPR/Cas9 and CRISPR/Cas12a systems suffer from inflexible target selection and low editing efficiency in fish gene editing, especially in aquaculture fish where new germplasm creation requires higher costs and longer cycles.

Method used

The Cas-SF01 protein in the CRISPR/Cas system, combined with a 20-24 nt gRNA spacer sequence and a nuclear localization signal sequence, was introduced into fish embryos via microinjection, electroporation, particle bombardment, or viral vector delivery. Heat shock treatment at a specific temperature was then performed to improve gene editing efficiency.

Benefits of technology

It achieves high efficiency and flexibility in fish gene editing, enabling biallelic mutations and multi-target editing, and is suitable for improving economic traits in aquatic products, breeding new varieties, constructing disease models for model fish, developing bioreactors, and controlling fish populations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122484209B_ABST
    Figure CN122484209B_ABST
Patent Text Reader

Abstract

This invention relates to the field of genetic engineering technology, and more particularly to a gene editing method and its application in fish. Based on the Cas-SF01 nuclease, this invention develops a highly efficient gene editing method suitable for fish. Compared to the CRISPR / Cas9 system, it expands the range of gene editing targets in fish, offers greater flexibility, and can achieve bicelestem mutations in target genes. It exhibits high and stable gene editing efficiency in various fish species. This invention provides a highly efficient gene editing method for fish, with broad application prospects in areas such as genetic improvement of economic traits in aquaculture and breeding of new varieties, construction of disease models in model fish, development of bioreactors, fish population control, and management of invasive species.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of genetic engineering technology, and in particular to a method and application of gene editing in fish. Background Technology

[0002] To date, gene editing systems used in fish mainly include ZFN, TALENs, and CRISPR / Cas9. Among them, CRISPR / Cas9 has become the mainstream gene editing system in fish due to its simple construction and ease of use. In addition, there are a few reports of the CRISPR-derived Cas12a protein family being used in fish, but the editing efficiency of the CRISPR / Cas12a system is lower than that of the CRISPR / Cas9 system.

[0003] To improve the gene editing efficiency of CRISPR / Cas9, researchers have employed various methods, including protein engineering to enhance the binding and cleavage capabilities of the Cas enzyme, optimizing the guide RNA structure to improve its stability, and altering the spacer length of the guide RNA to enhance its ability to recognize DNA targets. Furthermore, environmental factors such as temperature also affect the gene editing efficacy of the Cas enzyme.

[0004] However, the CRISPR / Cas9 and CRISPR / Cas12a systems still have significant technical limitations. Specifically: In the CRISPR / Cas9 system, prototypical spacer adjacent motifs (PAMs) exhibit a significant GC bias. This limits the ability to target AT-rich regions in the genome and reduces the flexibility of target selection. Furthermore, Cas9 carries a high risk of off-target effects, potentially triggering unexpected genomic variations that could pose a threat to the biosafety and genetic stability of the edited individual.

[0005] The CRISPR / Cas12a system typically exhibits a lower off-target rate than Cas9, offering advantages in biosafety and greater flexibility in target selection. However, practical experience with some fish species has shown that the system's editing efficiency is relatively low. Given that the reproductive cycles of farmed fish are often measured in years, with some major freshwater fish like grass carp reaching sexual maturity in as little as five years, low editing efficiency would necessitate higher costs and longer development cycles for creating new germplasm.

[0006] Therefore, developing efficient gene editing methods suitable for fish has become a pressing technical challenge in this field. Summary of the Invention

[0007] To address the aforementioned technical challenges, this invention provides a fish gene editing method for non-disease diagnosis and treatment purposes, comprising: performing gene editing on fish using a CRISPR / Cas system, wherein the Cas protein in the CRISPR / Cas system contains Cas-SF01 protein (i.e., Cas-SF01 nuclease), and the amino acid sequence of the Cas-SF01 protein is shown in SEQ ID No. 1.

[0008] This invention, through screening of various nucleases, discovered that the Cas-SF01 protein, a member of the Cas12I family, exhibits high gene editing efficiency in fish and demonstrates good applicability in fish.

[0009] Preferably, the nucleotide sequence of the gene encoding the Cas-SF01 protein is shown in SEQ ID No. 2.

[0010] The aforementioned coding genes are codon-optimized gene sequences that can improve translation efficiency in fish organisms, thereby enhancing editing efficiency.

[0011] In some embodiments, the Cas protein also contains a nuclear localization signal sequence.

[0012] Preferably, the nuclear localization signal sequence is located on both sides of the Cas-SF01 protein.

[0013] The nuclear positioning signal sequence can be any sequence disclosed in the art.

[0014] In some implementations, the spacer sequence of the gRNA in the CRISPR / Cas system is 20-24 nt in length.

[0015] The present invention further discovered that in the CRISPR / Cas system using the Cas-SF01 protein, the gene editing efficiency is higher when the length of the gRNA spacer sequence is controlled at 20-24 nt.

[0016] Preferably, the length of the gRNA spacer in the CRISPR / Cas system is 20 nt.

[0017] When the length of the spacer sequence of the gRNA is controlled to be 20 nt, the gene editing efficiency in fish is as high as 61% or more, more preferably 63% or more, more preferably 72% or more, and more preferably 93% or more.

[0018] In some embodiments, the stem-loop structure of the gRNA has the sequence shown in SEQ ID No. 11.

[0019] Preferably, the nucleotides at the 5' and / or 3' ends of the gRNA are modified with phosphate thioesters.

[0020] When the nucleotides at the 5' and / or 3' ends of gRNA are modified with phosphate thioesters, the stability of gRNA can be improved, thereby further enhancing gene editing efficiency.

[0021] More preferably, the ribosyl groups of three nucleotides at the 5' and 3' ends of the gRNA are modified with phosphate thioesters.

[0022] The present invention has found that by using the above-mentioned modification method and modification location, the gene editing efficiency of fish can be significantly improved, by 1.2 times.

[0023] Preferably, the specific steps for gene editing in fish using the CRISPR / Cas system include: introducing the Cas protein and the gRNA of the target gene into fish embryos, and then transferring them to 25°C to 30°C for culture after heat shock at 22°C to 34°C.

[0024] Preferably, after heat shock at 33℃~34℃ for 2~6h, the culture is transferred to 26℃~30℃ for incubation.

[0025] Most preferably, the cells are heat-shocked at 34°C for 4 hours and then transferred to 28°C for incubation.

[0026] The present invention further discovered that heat shock at the above-mentioned temperature can significantly improve the efficiency of gene editing in fish.

[0027] The fish gene editing method of the present invention can induce bicelestem mutations in target genes and can simultaneously achieve efficient gene editing of more than three target sites.

[0028] Preferably, the fish species of the present invention are bony fish.

[0029] In some implementations, the fish are freshwater farmed fish, aquaculture fish, or economically important fish.

[0030] In some implementations, the fish species include, but are not limited to, zebrafish, medaka, carp, tilapia, or salmon.

[0031] In some implementations, the delivery methods include, but are not limited to: microinjection, electroporation, particle bombardment, viral vector delivery, and ligand-nanoparticle complex delivery.

[0032] In some implementations, the Cas protein is introduced in the form of mRNA.

[0033] In some implementations, the fish embryo is a fertilized fish egg.

[0034] In some implementations, the results of the gene editing include, but are not limited to: gene knockout, gene knock-in, point mutation, fragment deletion or duplication or inversion, or epigenetic modification.

[0035] Furthermore, the present invention provides the application of the described fish gene editing method in at least one of the following aspects: (1) Genetic improvement of economic traits in aquatic products and breeding of new varieties; (2) Construction of disease models in model fish; (3) Bioreactor development; (4) Fish population control and invasive species management.

[0036] In some implementation schemes, the goals of genetic improvement of aquatic economic traits and breeding of new varieties include, but are not limited to: improving growth performance, enhancing disease and stress resistance, regulating reproductive traits, or optimizing product quality.

[0037] In some implementations, by using the fish gene editing method of the present invention to construct model fish disease models, disease-related genes can be studied and then used for drug preparation, drug screening, or evaluation.

[0038] In some implementation schemes, transgenic fish strains that can stably and efficiently express high-value medicinal proteins or industrial enzymes are constructed by targeting and integrating exogenous genes into specific safe sites in the fish genome.

[0039] In some implementations, creating sterile prototype strains by editing genes essential for fish reproduction can provide new technological tools for controlling invasive fish populations or the ecological impacts of aquaculture escaped fish.

[0040] Compared with the prior art, the beneficial effects of the present invention are as follows: This invention develops a highly efficient gene editing method for fish based on the Cas-SF01 nuclease. Compared to the CRISPR / Cas9 system, it expands the range of gene editing targets in fish, offers greater flexibility, and can achieve bicelestem mutations in target genes. It demonstrates high and stable gene editing efficiency in various fish species. This invention provides a highly efficient gene editing method for fish, with broad application prospects in areas such as genetic improvement of economic traits in aquaculture and breeding of new varieties, construction of disease models in model fish, bioreactor development, fish population control, and management of invasive species. Attached Figure Description

[0041] Figure 1 This is a diagram showing the results of Cas-SF01 nuclease editing the tyrosinase gene in zebrafish.

[0042] Figure 2This image shows the results of tyrosinase gene editing in zebrafish using different Cas nucleases, including the Cas-SF01 knockout method. tyr Albinism subsequently occurred, while no albinism occurred after injection of other nuclease mRNAs (scale bar: 200 μm).

[0043] Figure 3 The results show the prokaryotic expression and purification of Cas-SF01 protein. In the table, M is the marker, NC is the blank control, FL is the protein flow-through buffer, E1 is elution buffer 1, E2 is elution buffer 2, W is the washing buffer, B is the nickel column after elution, and 1-3 are the concentrated purified protein solutions.

[0044] Figure 4 This is a graph showing the gene editing results under different conditions, including the length of the spacer sequence of different gRNAs, different chemical modifications of gRNAs, and different temperature treatments. In the graph, A represents the gene editing efficiency based on the length of the spacer sequence of different gRNAs; B represents the gene editing efficiency based on different chemical modifications of gRNAs; the number of embryos evaluated in each group in A and B is marked with dots in the bar chart; and C represents the gene editing efficiency under different temperature treatments.

[0045] Figure 5 The present invention relates to a gene editing method for zebrafish. tyr Gene, alb Genes and ntl The result of simultaneous gene editing; where A1 is the target gene. tyr The gene shows allele knockout Sanger sequencing peaks. tyr The control group is the original sequencing peak diagram; replicates 1-3 of Cas-SF01 KO are replicates to verify allele knockout; A2 is the albino phenotype diagram; Cas-SF01 KO is the gene-edited zebrafish; B1 is the targeted... ntl The gene shows allele knockout Sanger peaks. ntl The control group shows the original sequencing peak diagram; replicates 1-3 of Cas-SF01 KO are replicates to verify allele knockout; B2 shows the tail-cutting phenotype; Cas-SF01 KO shows the gene-edited zebrafish; C1 shows the targeted... alb The gene shows allele knockout Sanger peaks. alb The control is the original sequencing peak diagram; Cas-SF01 KO replicates 1-3 are replicates to verify that it is an allele knockout; C2 is the albino phenotype diagram; Cas-SF01 KO is the gene-edited zebrafish.

[0046] Figure 6 The results are experimental findings validating the gene-editing method for fish in this invention in medaka and carp; where A represents the target medaka. tyr Gene knockout Sanger peaks appear in medaka. tyr The control group is the original sequencing peak diagram; replicates 1-3 of Cas-SF01 KO are replicates to verify allele knockout; B is the albino phenotype diagram of Cas-SF01 KO. tyr For mutation tyr Genetically modified medaka; C is the target carp ntl The gene shows allele knockout Sanger peaks. ntl The control group is the original sequencing peak diagram. Cas-SF01 KO replicates 1-3 are replicates validating its gene editing efficiency at 68%, 63%, and 66%, respectively; D is the tail-severed phenotype diagram for Cas-SF01 KO. ntl These are gene-edited carp.

[0047] Figure 7 This is an experimental design comparing the gene editing efficiency of the present invention with that of SpCas9 (Cas9) and LbCas12a in zebrafish. In this design, A represents the design of target sites of Cas-SF01, Cas9 and LbCas12a at the same or adjacent sites on different genes. Cas-SF01 and LbCas12a recognize the PAM sequence of TTTN (pink letter, N is any base) or GTTC (green letter), while Cas9 recognizes the PAM sequence of NGG (orange letter, N is any base). B is a heatmap of the editing efficiency of Cas-SF01, Cas9 and LbCas12a, with darker colors representing higher efficiency. Detailed Implementation

[0048] To make the objectives, technical solutions, and advantages of this invention clearer, the technical solutions of this invention will be clearly and completely described below. Obviously, the described embodiments are only some embodiments of this invention, not all embodiments. Based on the embodiments of this invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of this invention.

[0049] In the embodiments provided in this specification, unless specific techniques or conditions are specified, the techniques or conditions described in the literature in this field, or the product instructions, shall be followed. Reagents or instruments whose manufacturers are not specified are all conventional products that can be purchased from legitimate channels.

[0050] This invention relates to molecular biology experiments. Unless otherwise specified, reference can be made to the book *Molecular Cloning* (J. Sambrook, E.F. Fritsch, and T. Maniatis, Science Press, 1994). This book and its subsequent editions are the most commonly used and guiding reference books for those skilled in the art when performing experiments related to molecular biology. In addition, depending on the experimental purpose, those skilled in the art complete the corresponding experiments under the guidance of the operating manuals accompanying various commercial reagent kits or entrust them to specialized companies, such as primer synthesis and gene sequencing.

[0051] Example 1 This embodiment screens and identifies Cas nucleases with high gene-editing activity in fish, and the steps are as follows: Targeting the zebrafish tyrosinase gene ( tyr A gene, whose mutation leads to loss of pigmentation in the eyes and body, was used to design and synthesize multiple gRNAs (Table 1, the spacer sequences of the gRNAs are complementary to the target sequences). Four nucleases, Cas12j8, Cas12j19, enAsCas12f, and Cas-SF01 (with LbCas12a as a control), optimized with zebrafish codons, were used, with SV40 nuclear localization signals added to the 5' end and nucleoplasmic protein nuclear localization signals added to the 3' end. The mRNA (final concentration 300 ng / μL, aqueous solution) was mixed with the corresponding gRNA (final concentration 100 ng / μL, aqueous solution), and 1 nmL of the mixture was introduced into zebrafish fertilized eggs via microinjection and cultured at 28°C.

[0052] The amino acid sequence of the Cas-SF01 nuclease is shown in SEQ ID No. 1, and its encoding gene is shown in SEQ ID No. 2; the amino acid sequence of the Cas12j8 nuclease is shown in SEQ ID No. 3, and its encoding gene is shown in SEQ ID No. 4; the amino acid sequence of the Cas12j19 nuclease is shown in SEQ ID No. 5, and its encoding gene is shown in SEQ ID No. 6; the amino acid sequence of the enAsCas12f nuclease is shown in SEQ ID No. 7, and its encoding gene is shown in SEQ ID No. 8; and the amino acid sequence of the LbCas12a nuclease is shown in SEQ ID No. 9, and its encoding gene is shown in SEQ ID No. 10.

[0053] The amino acid sequence of the SV40 nuclear localization signal is shown in SEQ ID No. 11, and its encoding gene is shown in SEQ ID No. 12; the amino acid sequence of the nucleoplasmic protein nuclear localization signal is shown in SEQ ID No. 13, and its encoding gene is shown in SEQ ID No. 14; the stem-loop structure sequence of the Cas-SF01 gRNA is shown in SEQ ID No. 15; the stem-loop structure sequence of the Cas12j8 gRNA is shown in SEQ ID No. 16; the stem-loop structure sequence of the Cas12j19 gRNA is shown in SEQ ID No. 17; the stem-loop structure sequence of the enAsCas12f gRNA is shown in SEQ ID No. 18; and the stem-loop structure sequence of the LbCas12a gRNA is shown in SEQ ID No. 19.

[0054] Table 1

[0055] Embryos were cultured at 28.5℃ after injection. After 2-3 days of culture, the embryos were observed under a stereomicroscope to detect the albinism phenotype. The number of embryos with albinism and the degree of albinism in each injection group were counted. Genomic DNA was extracted from the embryos and PCR amplified using the primers shown in SEQ ID No. 20 and SEQ ID No. 21 to obtain PCR products containing the editing sites.

[0056] SEQ ID No. 20 (ztyr-F): tctcactctcctcgactcttc SEQ ID No. 21 (ztyr-R): gtagtttccggcgcactggcag After purification, the PCR products were subjected to Sanger sequencing. The sequenced sequences were uploaded to the CRISPR editing inference platform (ICE, https: / / ice.synthego.com / # / ) to quantitatively calculate the frequency of insertions and deletions in order to assess the overall editing efficiency.

[0057] The results showed that only the Cas-SF01 injection group exhibited a significant albinism phenotype and a 15% editing efficiency. Figure 1 The remaining groups showed no visible phenotypes and had no editing efficiency. Figure 2 This led to the identification of Cas-SF01 as the first member of the Cas12I family with high gene-editing activity in fish.

[0058] Furthermore, in this embodiment, the Cas-SF01 protein was expressed and purified in prokaryotes, and the steps are as follows: Using pET30a plasmid (Novagen) as a backbone, restriction endonucleases NdeI and NotI were used for digestion. The codon-optimized Cas-SF01 coding gene sequence, with nuclear localization signal sequences at both ends (as described above), was inserted into the plasmid to obtain the pET30a-Cas-SF01 recombinant plasmid. This plasmid was transformed into DE3 *E. coli* and cultured with shaking at 37°C. Isopropyl-β-D-thiogalactoside (IPTG) was added to a final concentration of 0.2 mM, and expression was induced at 150 rpm and 16°C for 24 hours. Cells were sonicated at 4°C for 60 minutes, followed by centrifugation at 7000×g for 20 minutes at 4°C. The supernatant was then passed through a Ni-NTAHis•Bind Resin nickel column, and the loading was repeated three times to improve binding efficiency. Wash with 10 column volumes of washing buffer (20 mM Tris-HCl pH 8.0, 300 mM NaCl, 20 mM imidazole, 1 mM PMSF), then elute the target protein with elution buffer (20 mM Tris-HCl pH 8.0, 300 mM NaCl, 250 mM imidazole, 1 mM PMSF). Figure 3 The eluent was further purified by size exclusion chromatography (SEC), and the peak components were collected and concentrated using an Amicon® Ultra centrifugal filter with a molecular weight cutoff of 50 kDa. The final product was the Cas-SF01 protein with nuclear localization signal sequences at both ends, as shown in SEQ ID No. 22, which was used for experiments in subsequent examples.

[0059] SEQ ID No. 22: Example 2 This embodiment investigates the optimal gRNA spacer length, gRNA chemical modification, and temperature treatment conditions of the Cas-SF01 nuclease. The steps are as follows: Targeted zebrafish with lengths of 16 nt (ccccgagtctgcacct, SEQ ID No. 23), 18 nt (ccccgagtctgcacctcc, SEQ ID No. 24), 20 nt (ccccgagtctgcacctcccc, SEQ ID No. 25), 22 nt (ccccgagtctgcacctccccag, SEQ ID No. 26), and 24 nt (ccccgagtctgcacctccccagaa, SEQ ID No. 27) were designed and synthesized. tyr The spacer sequence of the gRNA of the gene (the stem-loop structure sequence of the gRNA is shown in SEQ ID No. 15) was injected and cultured with the Cas-SF01 protein with nuclear localization signal sequences at both ends in Example 1 to form a ribonucleoprotein complex (RNP complex).

[0060] Gene editing efficiency was compared by sequencing, and the average editing efficiency of 20 nt was determined to be 61%, which was superior to that of 16 nt (2.75%), 18 nt (12.5%), 22 nt (44.75%) and 24 nt (39%). Figure 4 (A in the middle).

[0061] Based on this, the 20 nt gRNA was chemically modified: CCC was added to the 5' end and TTTT was added to the 3' end, followed by 3' phosphate thioester modification at each ribosome of the three nucleotides at the 3' end of the gRNA (denoted as M1 modification), or 3' phosphate thioester modification at each ribosome of the three nucleotides at the 5' and 3' ends of the gRNA (denoted as M2 modification). Injection and culture were performed according to the method in Example 1, and the average editing efficiency of M1- and M2-modified gRNAs and unmodified gRNAs (in vitro transcription, native group) was compared. The results showed that the editing efficiency of the M2-modified gRNA was 72.8%, significantly higher than that of the in vitro transcribed (48.6%) and M1-modified gRNAs (48.75%). Figure 4 (B in the middle).

[0062] Based on this, the temperature treatment conditions were investigated: Zebrafish embryos injected with Cas-SF01 protein with nuclear localization signal sequences at both ends and gRNA with the 20nt spacer sequence modified by M2 as described above were heat-shocked at different temperatures (22℃, 25℃, 28℃, 34℃) for 4 hours and then transferred to 28℃ for further culture.

[0063] The results showed that gene editing efficiency gradually increased with moderate temperature increase: 29% at 22℃, 55.53% at 25℃, and 79.33% at 28℃. After a 4-hour heat shock treatment at 34℃, the gene editing efficiency reached its optimal value of 93%. Figure 4 (C in the middle).

[0064] Example 3 This embodiment, based on Embodiment 2, uses optimal conditions for zebrafish. tyr Gene, alb Genes and ntl Gene editing is performed simultaneously, following these steps: For zebrafish tyr Gene (target sequence shown in SEQ ID No. 28), alb Gene (target sequence shown in SEQ ID No. 29) and ntl Genes (target sequence shown in SEQ ID No. 30) were used to design gRNA sequences. The spacer sequence of each gRNA was 20 nt in length, and the stem-loop structure of the gRNA was shown in SEQ ID No. 15. The gRNAs were modified with M2. A Cas-SF01 protein (SEQ ID No. 22) with nuclear localization signal sequences at both ends, at a final concentration of 5 μM, was mixed with the gRNA at a final concentration of 5 μM to form an RNP complex. 1 nL was injected into each single-cell zebrafish embryo, followed by heat shock at 34°C for 4 hours, and then cultured at 28°C. One day later, zebrafish embryos were collected, genomic DNA was extracted, and the target site was amplified by PCR followed by sequencing. Primers are shown in SEQ ID No. 31–SEQ ID No. 36. Alignment with the original sequence was used to determine whether biallelic mutations occurred.

[0065] SEQ ID No.28:ccccgagtctgcacctcccc SEQ ID No.29:gaagggaattctgctacgct SEQ ID No.30: agaagggcagcgagaaaggg SEQ ID No.31 ( ntl upstream primer of gene): agcttcgtatcgggccttta SEQ ID No.32 ( ntl Downstream primers for the gene): acctcccagtcttggtgaca SEQ ID No.33 ( tyr upstream primer of gene): tctcactctcctcgactcttc SEQ ID No.34 ( tyr (Gene downstream primer): gtagtttccggcgcactggcag SEQ ID No.35 ( alb upstream primer of gene): caccacctccttgccttctc SEQ ID No.36 ( alb Downstream primer for gene): cgatgacgggctgtaggataaa The results showed that the embryos exhibited a completely albino phenotype after injection. tyr and alb ) or tail developmental defect phenotype ( ntl ). Tyr The mutation efficiency is 97%. alb The mutation efficiency is 93%. ntl The mutation efficiency was 92%. After sequencing and alignment with the original sequence, biallelic mutations were observed in all sequences. Figure 5 ).

[0066] Example 4 This embodiment uses the gene editing method of Example 3 to verify the applicability of the method in medaka. The only difference between this embodiment and Example 3 is the following steps: For medaka tyr The gene synthesizes gRNA, and the target sequence is shown in SEQ ID No. 37.

[0067] The primers used for PCR amplification are shown in SEQ ID No. 38 and SEQ ID No. 39.

[0068] SEQ ID No.37: aggggactgcgaaccaagg SEQ ID No.38: ggacagatgtgggtgaatcttt SEQ ID No.39: gttgaagaaagctaaaggccag The results showed that the target site underwent a biallelic mutation ( Figure 6 (A) After hatching, the embryonic somatic pigment phenotype was observed under a stereomicroscope. The results showed that the injected F0 generation medaka embryos exhibited a completely significant albino phenotype (…). Figure 6(B in the above results) confirms that the fish gene editing method established in this invention is applicable to medaka.

[0069] Example 5 This embodiment uses the gene editing method of Example 3 to verify the applicability of the method in carp. The only difference between this embodiment and Example 3 is the following steps: For carp ntl The gene (a key gene for tail development) synthesizes gRNA, with the target sequence shown in SEQ ID No. 40. The primers used for PCR amplification are shown in SEQ ID No. 41 and SEQ ID No. 42.

[0070] SEQ ID No.40: gggtcgaggcttctgccagg SEQ ID No.41: aacgggcctcgatgtatgtc SEQ ID No.42: taacgatgaccgacgcgaaa The results showed that the target site underwent a biallelic mutation ( Figure 6 (C) After hatching, the tail morphology of the embryos was observed under a stereomicroscope. The results showed that the F0 generation carp embryos after injection exhibited obvious tail development defects (tail breakage) phenotype. Figure 6 (D in the original text). The above results confirm that the fish gene editing method established in this invention is also applicable to carp.

[0071] Comparative Example This comparative example provides a gene editing method, differing only from Example 1 in that: SpCas9 protein solution (Cas9 protein, amino acid sequence shown in SEQ ID No. 43), LbCas12a protein solution, and Cas-SF01 protein solution of the same concentration are used instead of mRNA solution for gene editing. Simultaneously, the corresponding stem-loop sequences of the three gRNAs are used: the stem-loop structure sequence of Cas-SF01 gRNA is shown in SEQ ID No. 15, the stem-loop structure sequence of LbCas12a gRNA is shown in SEQ ID No. 19, and the stem-loop structure sequence of SpCas9 gRNA is shown in SEQ ID No. 44. Target sites are designed at the same or adjacent positions in the same gene (…). Figure 7 ).

[0072] SEQ ID No. 43: SEQ ID No.44: GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGC The results showed that the Cas9 protein was effective against zebrafish. tyr Gene, alb Genes and ntl The gene editing efficiencies were 6%, 92%, and 4% for LbCas12a protein in zebrafish. tyr Gene, alb Genes and ntl The gene editing efficiencies were 0%, 66%, and 0%, all lower than those of the Cas-SF01 protein (85%, 93%, and 92%, respectively).

[0073] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, and not to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some of the technical features; and these modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A method for gene editing in fish for purposes other than disease diagnosis and treatment, characterized in that, include: Gene editing in fish was performed using the CRISPR / Cas system. The Cas protein in the CRISPR / Cas system contains the Cas-SF01 protein, the amino acid sequence of which is shown in SEQ ID No.

1. The spacer sequence of the gRNA in the CRISPR / Cas system is 20 nt in length. The ribosyl groups of the three nucleotides at the 5' and 3' ends of the gRNA are modified with phosphate thioester. The specific steps for gene editing in fish using the CRISPR / Cas system include: introducing the Cas protein and gRNA of the target gene into fish embryos, heat-shocking them at 34°C for 4 hours, and then transferring them to 28°C for culture; The fish in question are bony fish.

2. The fish gene editing method according to claim 1, characterized in that, The nucleotide sequence of the gene encoding the Cas-SF01 protein is shown in SEQ ID No.

2.

3. The fish gene editing method according to claim 1 or 2, characterized in that, The Cas protein also contains a nuclear localization signal sequence.

4. The fish gene editing method according to claim 1 or 2, characterized in that, The purpose of implementing the fish gene editing method is to achieve biallelic mutations.

Citation Information

Patent Citations

  • Optimized Cas protein and application thereof

    CN118006585A